Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Decisions

<< Previous

Bullboard Posts

Next >>

Comment by Biobobon May 20, 2022 11:03am

63 Views

Post# 34698330

RE:RE:RE:Decisions

I don't think they CAN put out equity without somekind of positive signs on Th1902... would you buy the deal even at 2$ without hope... if they try they are finished, the deal will be pulled before the closing.

<< Previous

Bullboard Posts

Next >>

Three mispriced stocks exposed to major market tailwinds